Sarivan, also known as Tephrosia purpurea, has a longstanding presence in traditional Ayurvedic medicine, where it is used to support liver health and manage various hepatic disorders, including hepatitis. The use of Sarivan for hepatitis is primarily rooted in traditional practice rather than robust scientific evidence. In Ayurveda, the plant is considered to have hepatoprotective properties and is included in several classical formulations aimed at promoting liver function and addressing symptoms associated with liver inflammation.

Scientific studies on Sarivan’s efficacy in treating hepatitis are limited. Some preclinical research—primarily in vitro and animal models—suggests that extracts of Tephrosia purpurea may exhibit hepatoprotective effects, possibly by reducing oxidative stress and inflammation in liver tissue. However, these findings have not been consistently validated in well-designed human clinical trials, and the specific impact on viral hepatitis (such as hepatitis B or C) remains unclear.

Overall, the justification for using Sarivan in hepatitis is based more on traditional Ayurvedic concepts and its historical use as a liver tonic, with only modest scientific support from preliminary studies. High-quality clinical evidence remains lacking, and thus its use should be considered as complementary rather than primary or evidence-based therapy for hepatitis.